Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation TCT 2023

State-of-the-art Lecture on Evidence for MCS in Cardiogenic Shock

Presenter: Holger Thiele

October 26, 2023

Presentation TCT 2023

Optimal Antithrombotic Strategies in MCS Use

Presenter: Mirvat Alasnag

October 26, 2023

Presentation TCT 2023

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Presenter: Sanjit Jolly

October 24, 2023

Presentation TCT 2023

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

Presenter: William O'Neill

October 24, 2023

Presentation TCT 2023

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

Presenter: Haroon Faraz

October 24, 2023

Presentation TCT 2023

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Presenter: Nicolas Van Mieghem

October 23, 2023

Presentation THT 2023

Acute MR With MCS/TEER

Presenter: Thomas Waggoner

March 21, 2023

Presentation THT 2023

Cardiogenic Shock With MCS and Review of Shock Algorithm

Presenter: Raymond Yau

March 21, 2023

Presentation THT 2023

Assessing RV Function in Cardiogenic Shock: When to Pull the Trigger on MCS

Presenter: Arthur Reshad Garan

March 21, 2023

Presentation THT 2023

Role of Temporary MCS in Pulmonary Arterial Hypertension

Presenter: Eduardo Rame

March 21, 2023

Presentation THT 2023

Novel applications for counterpulsation

Presenter: Ran Lee

March 21, 2023

Presentation THT 2023

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

Presenter: A. Reshad Garan

March 21, 2023

Presentation THT 2023

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Presenter: Rachna Kataria

March 21, 2023

Presentation THT 2023

Principles and unique physiological effects characteristic of counterpulsation

Presenter: Arvind Bhimaraj

March 21, 2023

Presentation THT 2023

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Presenter: Jonathan Menachem

March 20, 2023

Advertisement

State-of-the-art Lecture on Evidence for MCS in Cardiogenic Shock

Optimal Antithrombotic Strategies in MCS Use

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Acute MR With MCS/TEER

Cardiogenic Shock With MCS and Review of Shock Algorithm

Assessing RV Function in Cardiogenic Shock: When to Pull the Trigger on MCS

Role of Temporary MCS in Pulmonary Arterial Hypertension

Novel applications for counterpulsation

Predictors for a positive hemodynamic & clinical response to intra-aortic counterpulsation

MCS strategies guided by ischemic vs. non-ischemic etiology and HF clinical phenotyping

Principles and unique physiological effects characteristic of counterpulsation

What's the Status of Advanced Heart Failure Care in ACHD Now? MCS, Listing Status and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content